Zobrazeno 1 - 10
of 137
pro vyhledávání: '"F. Friedlos"'
Publikováno v:
Gene Therapy. 5:105-112
Clones of human colon carcinoma (WiDr), ovarian carcinoma (SK-OV-3), and Chinese hamster V79 cells expressing the nitroreductase enzyme (NR) from E. coli B were 52-, 225- and 177-fold respectively more sensitive to a 24-h incubation with the prodrug
Publikováno v:
Anti-cancer drug design. 14(6)
Antibody- and gene-directed enzyme prodrug therapy are two-step targeting strategies designed to improve the selectivity of antitumour agents. The approaches are based on the activation of specially designed prodrugs by antibody-enzyme conjugates tar
Autor:
S. J. Weedon, David J. Kerr, Peter F. Searle, Caroline J. Springer, Lawrence S. Young, Iain A. McNeish, Moira G. Gilligan, F. Friedlos, M. J. Ford
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461374442
The enzyme nitroreductase from E. coli can reduce the relatively non-toxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) to the 2- or 4-hydroxylamino derivatives; the latter is a potent cytotoxic agent, which following further non-enzymatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::842bb9d2c2544519c87f9a4862471891
https://doi.org/10.1007/978-1-4615-5357-1_17
https://doi.org/10.1007/978-1-4615-5357-1_17
Autor:
S, Chen, R, Knox, A D, Lewis, F, Friedlos, P, Workman, P S, Deng, M, Fung, D, Ebenstein, K, Wu, T M, Tsai
Publikováno v:
Molecular pharmacology. 47(5)
NAD(P):quinone acceptor oxidoreductase (quinone reductase) (DT-diaphorase, EC 1.6.99.2) is involved in the process of reductive activation of cytotoxic antitumor quinones and nitrobenzenes. In this study, we initially examined the relative abilities
Publikováno v:
Biochemical pharmacology. 44(12)
A nitroreductase enzyme that has been isolated from Escherichia coli B is capable of bioactivating CB1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide] to a cytotoxic agent, a property shared with the mammalian enzyme Walker DT diaphorase [NAD(P)H dehydro
Publikováno v:
Biochemical pharmacology. 44(12)
A nitroreductase enzyme has been isolated from Escherichia coli B. This enzyme is an FMN-containing flavoprotein with a molecular mass of 24 kDa and requires either NADH or NADPH as a cofactor. Partial protein sequence analysis showed extensive homol
Autor:
F, Friedlos, R J, Knox
Publikováno v:
Biochemical pharmacology. 44(4)
NADH was metabolized both by serum components and at the cell surface. The metabolism by serum was either oxidation to NAD+, or hydrolysis of the pyrophosphate to yield nicotinamide mononucleotide (reduced) (NMNH) and AMP. NMNH was further hydrolysed
Publikováno v:
Biochemical pharmacology. 43(6)
CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide) becomes, upon bioactivation, a difunctional alkylating agent. It can be up to a 100,000-fold more cytotoxic in cells that are able to bioactivate it than in those that cannot. This increase in cytotoxi
Publikováno v:
European Journal of Cancer. 30:S8
Publikováno v:
Chemico-Biological Interactions. 17:265-290
The lethal and chromosome damaging effects of 7-bromomethylbenz(a)anthracene (7-BMBA) on Chinese hamster cells in culture were enhanced by posttreatment incubation in non-toxic concentrations of caffeine. 7-BMBA produced a marked dose-dependent depre